Literature DB >> 8382268

Symptomatic Epstein-Barr virus infection and multiple sclerosis.

C N Martyn1, M Cruddas, D A Compston.   

Abstract

In a case-control study of 214 patients with multiple sclerosis, recall of infectious mononucleosis in subjects seropositive for Epstein-Barr viral capsid antigen was associated with a relative risk of 2.9 (95% CI 1.1 to 7.2). Those who reported having infectious mononucleosis before the age of 18 years had a relative risk of multiple sclerosis of 7.9 (95% CI 1.7 to 37.9). The pathogenesis of multiple sclerosis may involve an age-dependent host response to Epstein-Barr virus infection.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8382268      PMCID： PMC1014816          DOI： 10.1136/jnnp.56.2.167

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  3 in total

1.  A case-control study of multiple sclerosis.

Authors:  E A Operskalski; B R Visscher; R M Malmgren; R Detels
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

2.  Multiple sclerosis and Epstein-Barr virus.

Authors:  H B Warner; R I Carp
Journal:  Lancet       Date:  1981-12-05       Impact factor: 79.321

3.  Viral infection in patients with multiple sclerosis and HLA-DR matched controls.

Authors:  D A Compston; B N Vakarelis; E Paul; W I McDonald; J R Batchelor; C A Mims
Journal:  Brain       Date:  1986-04       Impact factor: 13.501
  3 in total
  17 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

2.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 4.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 5.  Multiple sclerosis and the role of immune cells.

Authors:  Rune A Høglund; Azzam A Maghazachi
Journal:  World J Exp Med       Date:  2014-08-20

6.  Epstein-Barr virus and disease activity in multiple sclerosis.

Authors:  D Buljevac; G J J van Doornum; H Z Flach; J Groen; A D M E Osterhaus; W Hop; P A van Doorn; F G A van der Meché; R Q Hintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

7.  Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.

Authors:  Trygve Holmøy; Espen Østhagen Kvale; Frode Vartdal
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

8.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21

9.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

10.  Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis.

Authors:  Daniela Pohl; Kevin Rostasy; Christian Jacobi; Peter Lange; Roland Nau; Bernd Krone; Folker Hanefeld
Journal:  J Neurol       Date:  2009-08-28       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.